Total Payments
$9,910
2024 Payments
$740.34
Companies
40
Transactions
560
Medicare Patients
6,518
Medicare Billing
$516,865
Payment Breakdown by Category
Food & Beverage$9,089 (91.7%)
Travel$700.34 (7.1%)
Education$120.78 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,089 | 555 | 91.7% |
| Travel and Lodging | $700.34 | 1 | 7.1% |
| Education | $120.78 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,102 | 164 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,649 | 94 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,264 | 77 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $820.46 | 40 | $0 (2022) |
| ABIOMED | $740.34 | 2 | $0 (2024) |
| Insmed, Inc. | $482.73 | 18 | $0 (2022) |
| Advanced Respiratory, Inc | $343.58 | 22 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $277.40 | 18 | $0 (2018) |
| GENZYME CORPORATION | $252.83 | 13 | $0 (2022) |
| Philips Electronics North America Corporation | $171.92 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $740.34 | 2 | ABIOMED ($740.34) |
| 2023 | $18.94 | 1 | Philips Electronics North America Corporation ($18.94) |
| 2022 | $1,608 | 88 | AstraZeneca Pharmaceuticals LP ($362.55) |
| 2021 | $1,430 | 83 | AstraZeneca Pharmaceuticals LP ($276.56) |
| 2020 | $1,313 | 85 | GlaxoSmithKline, LLC. ($409.68) |
| 2019 | $2,080 | 121 | GlaxoSmithKline, LLC. ($439.88) |
| 2018 | $1,734 | 109 | GlaxoSmithKline, LLC. ($513.54) |
| 2017 | $987.29 | 71 | GlaxoSmithKline, LLC. ($307.35) |
All Payment Transactions
560 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $700.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $40.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Medical Device | ||||||
| 11/18/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Respiratory | ||||||
| 11/18/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Immunology | ||||||
| 11/17/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Respiratory | ||||||
| 10/13/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 10/04/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Respiratory | ||||||
| 10/01/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 09/06/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Cardiology | ||||||
| 09/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiology | ||||||
| 08/27/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Respiratory | ||||||
| 08/24/2022 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Airway Clearance Device | ||||||
| 08/22/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Respiratory | ||||||
| 08/19/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardiology | ||||||
| 08/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 08/08/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Inflammation | ||||||
| 08/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 183 | 212 | $105,757 | $28,521 |
| 2022 | 23 | 1,910 | 2,284 | $342,470 | $150,069 |
| 2021 | 32 | 2,064 | 4,585 | $378,688 | $165,698 |
| 2020 | 37 | 2,361 | 4,981 | $411,853 | $172,577 |
Total Patients
6,518
Total Services
12,062
Medicare Billing
$516,865
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 107 | 119 | $70,918 | $18,873 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $16,699 | $4,568 | 27.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 26 | $7,258 | $2,324 | 32.0% |
| 92950 | Manual attempt to restore blood circulation and breathing | Facility | 2023 | 11 | 11 | $5,951 | $1,513 | 25.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 21 | $4,931 | $1,243 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 208 | 321 | $69,978 | $41,457 | 59.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 359 | 427 | $69,174 | $37,190 | 53.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 79 | 79 | $24,806 | $12,914 | 52.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $21,000 | $10,284 | 49.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 450 | 540 | $28,080 | $10,178 | 36.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 54 | $28,836 | $9,099 | 31.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 143 | 157 | $14,601 | $6,569 | 45.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 129 | 143 | $13,442 | $5,667 | 42.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $14,653 | $5,107 | 34.9% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2022 | 19 | 19 | $7,144 | $2,635 | 36.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 67 | 68 | $5,984 | $1,889 | 31.6% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2022 | 20 | 20 | $3,860 | $1,478 | 38.3% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 23 | 23 | $8,648 | $1,203 | 13.9% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2022 | 11 | 11 | $5,104 | $1,185 | 23.2% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2022 | 19 | 19 | $2,527 | $973.57 | 38.5% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 17 | 17 | $5,454 | $642.30 | 11.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 37 | 42 | $1,092 | $602.21 | 55.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 22 | 22 | $1,430 | $520.16 | 36.4% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 31 | 31 | $9,052 | $254.74 | 2.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 13 | $455.00 | $138.49 | 30.4% |
About Dr. Christopher Parker, MD
Dr. Christopher Parker, MD is a Pulmonary Disease healthcare provider based in Norman, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1518251735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Parker, MD has received a total of $9,910 in payments from pharmaceutical and medical device companies, with $740.34 received in 2024. These payments were reported across 560 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($9,089).
As a Medicare-enrolled provider, Parker has provided services to 6,518 Medicare beneficiaries, totaling 12,062 services with total Medicare billing of $516,865. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine
- Location Norman, OK
- Active Since 06/06/2011
- Last Updated 04/29/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1518251735
Products in Payments
- TRELEGY ELLIPTA (Drug) $951.66
- OFEV (Drug) $800.71
- Impella (Device) $740.34
- SYMBICORT (Drug) $484.77
- NUCALA (Biological) $450.97
- Arikayce (Drug) $448.70
- FASENRA (Drug) $419.40
- OPSUMIT (Drug) $401.56
- BREZTRI (Drug) $376.99
- ANORO (Drug) $362.92
- UPTRAVI (Drug) $353.78
- The Vest System Model 105 Home Care (Device) $294.27
- DUPIXENT (Biological) $266.34
- STIOLTO RESPIMAT (Drug) $218.68
- BREO (Drug) $183.68
- TEZSPIRE (Biological) $168.17
- SPIRIVA RESPIMAT (Drug) $158.62
- XOLAIR (Biological) $144.52
- Adempas (Drug) $126.12
- GLASSIA (Biological) $121.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.